Phylogenetic placement, whole genome assembly, and genome-wide association study of Trichuris incognita: a novel human-infecting species causing trichuriasis, with low sensitivity to albendazole-ivermectin

Max A. Baer,Nadege A. Kouame,Sadikou Toure,Jean T. Coulibaly,Pierre H. H. Schneeberger,Jennifer Keiser
DOI: https://doi.org/10.1101/2024.06.11.598441
2024-09-28
Abstract:Trichuriasis is a neglected tropical disease that affects as many as 500 million individuals and can cause significant morbidity, even death. For decades, it is thought to be caused by one species of whipworm, Trichuris trichiura. Discrepancies in response rates to benzimidazole treatment for trichuriasis exist across clinical trial reports yet the underlying reasons are unclear, and the emergence of anthelmintic resistance is predicted to be established within the next decade. Here, we present the discovery of a novel Trichuris species, Trichuris incognita, causing trichuriasis, and we investigate variants in context of drug resistance. Combining long- and short- read sequencing approaches, we assembled a high-quality reference genome of Trichuris incognita to construct the species tree of the Trichuris genus using 12434 orthologous groups and we sequenced a total of 747 individual worms which confirmed the phylogenetic placement. Comparative genomic analysis of genes implied in the resistance of either albendazole or ivermectin in helminths revealed a high copy number of the beta-tubulin (TUBB) gene, present in the whole population, compared to the canonical T. trichiura species. A genome wide association study comparing 181 albendazole-ivermectin sensitive to 544 drug non-sensitive worms implied a HERC4 gene with genome wide significance, which has been reported to be downregulated by ivermectin. Our results demonstrate that trichuriasis can be caused by multiple species of whipworm, challenging the long-held belief that it is exclusively due to Trichuris trichiura. This discovery, coupled with decreased sensitivity to the best available anthelmintic treatment, a combination of albendazole and ivermectin, marks a significant shift in how we understand and approach whipworm infections. We anticipate our findings to have a profound impact on how we understand whipworm infections with implications on all present and future de-worming strategies across the globe.
Genomics
What problem does this paper attempt to address?